Skip to main content
. 2017 Dec 4;8(70):115114–115127. doi: 10.18632/oncotarget.22914

Figure 1. Time to multi-targeted tyrosine kinase inhibitor discontinuation.

Figure 1

Data represents mean and standard deviation. **Mann-Whitney U p-value < 0.0001.